TESSELLATE BIO
Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques. It develops precision oncology methods to treat tumors with significant unmet medical needs.
TESSELLATE BIO
Social Links:
Industry:
Biotechnology Medical Product Research
Founded:
2020-01-01
Address:
Naarden, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.tessellatebio.com
Total Employee:
11+
Status:
Active
Total Funding:
8 M EUR
Technology used in webpage:
Euro Combell
Current Advisors List
Current Employees Featured
Investors List
BioGeneration Ventures
BioGeneration Ventures investment in Seed Round - Tessellate BIO
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - Tessellate BIO
Official Site Inspections
http://www.tessellatebio.com Semrush global rank: 7.36 M Semrush visits lastest month: 804
- Host name: 185-152-66-243.bunnyinfra.net
- IP address: 185.152.66.243
- Location: Atlanta United States
- Latitude: 33.7553
- Longitude: -84.3886
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30303
More informations about "Tessellate BIO"
About – Tessellate Bio
Committed to Precision Medicine. We are leveraging a comprehensive development strategy early in our programs drive effective small molecule drug discovery towards novel, validated …See details»
Leadership – Tessellate Bio
Leadership. We are led by a seasoned team of established drug hunters and biotech entrepreneurs with a proven track record in targeting synthetic lethality, a strong medicinal chemistry background and a successful history of precision …See details»
Tessellate BIO - LinkedIn
Visit our website at www.tessellateBIO.com to find out more about ... My Green Lab is a non-profit organization which introduces sustainability to the community responsible for the world’s life ...See details»
Member profile: Tessellate Bio | BIA
Nov 4, 2024 Tessellate BIO is a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches. Its lead program targets the DNA damage response (DDR) …See details»
Tessellate BIO - Crunchbase Company Profile & Funding
Oct 17, 2023 Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques. It develops precision oncology methods to treat tumors with significant unmet medical needs.See details»
Tessellate Bio 2025 Company Profile: Valuation, …
Tessellate Bio General Information Description. Operator of a biotechnology company intended to address cancers that depend on synthetic lethality (SL) mechanisms. The company operates within the biotechnological research and …See details»
Tessellate BIO Emerges from StealthThe Next Generation
Oct 17, 2023 Andree Blaukat, CEO - [email protected]. Media Enquiries. Charles Consultants. Sue Charles – [email protected] +44 (0)7968 726585. …See details»
BioGeneration Ventures portfolio company Tessellate BIO emerges …
Oct 17, 2023 For more information, please visit: www.tessellatebio.com | follow us on LinkedIn. About Tessellate BIO’s lead program - ALT ALT is a critical mechanism to maintain the …See details»
Tessellate Bio - VentureRadar
Similar Companies: Satya Pharma India n/a Satya is a discovery biotech, developing next-generation small-molecule oncology therapeutics that focus on unique approaches to: …See details»
Tessellate BIO Company Profile - Craft
Tessellate BIO has 5 employees across 2 locations and $8.43 m in total funding,. See insights on Tessellate BIO including office locations, competitors, revenue, financials, executives, …See details»
Tessellate BIO - CMRI
Tessellate BIO, a biotechnology company whose vision is to become a global leader in precision medicines for cancer treatment that turn cancer patients into cancer survivors, is making its …See details»
Tessellate BIO, an Emerging Precision Oncology Company,
Nov 15, 2023 Andree Blaukat, CEO - [email protected]. Media Enquiries Charles Consultants Sue Charles – [email protected] +44 (0)7968 726585See details»
Forbion Portfolio company Tessellate BIO emerges from stealth
Oct 17, 2023 For more information, please visit: www.tessellatebio.com | follow us on LinkedIn. About Tessellate BIO’s lead program - ALT ALT is a critical mechanism to maintain the …See details»
Science – Tessellate Bio
Pioneering scientific approach to redefine synthetic lethality. Driven by a deep scientific understanding and leveraging our innovative experimental approaches, state-of the-art assays …See details»
Tessellate BIO, Omico and CMRI announce a multi-year ... - BioSpace
AMSTERDAM and SYDNEY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, …See details»
Tessellate BIO in historic cancer research initiative
Sep 29, 2024 Tessellate BIO, which has research labs at the Stevenage Bioscience Catalyst, has joined forces with Australasian power players Omico and Children's Medical Research …See details»
Tessellate BIO Emerges from Stealth
Oct 17, 2023 The Next Generation Synthetic Lethality Precision Oncology Company. The company aims to become a global leader in precision oncology by redefining Synthetic …See details»
Tessellate BIO Emerges from Stealth - GlobeNewswire
Oct 17, 2023 Andree Blaukat, CEO - [email protected]. Media Enquiries Charles Consultants Sue Charles – [email protected] +44 (0)7968 726585See details»
Boehringer Ingelheim and Tessellate Bio partner to develop first-in ...
2 days ago Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers . Ingelheim, Germany and Amsterdam, the …See details»
News & Events – Tessellate Bio
Oct 17, 2023 Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers 23 April 2025; Tessellate BIO Announces …See details»